Suchergebnisse - "Warr, David"

PubPharm (183)

1

Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic : recommendations from Ontario, Canada

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2020

von Grant, R. | Rotstein, C. | Liu, G. | +7

2

Supportive care in cancer-a MASCC perspective

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2020

von Olver, I. | Keefe, D. | Herrstedt, J. | +3

CommentIn: Support Care Cancer. 2021 Apr;29(4):1711-1712. - PMID 33392767

3

Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada

enthalten in: Supportive care in cancer | 2020

von Grant, R. | Rotstein, C. | Liu, G. | +7

4

Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada

enthalten in: Supportive care in cancer | 2020

von Grant, R. | Rotstein, C. | Liu, G. | +7

5

Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada

enthalten in: Supportive care in cancer | 2020

von Grant, R. | Rotstein, C. | Liu, G. | +7

6

Supportive care in cancer—a MASCC perspective

enthalten in: Supportive care in cancer | 2020

von Olver, I. | Keefe, D. | Herrstedt, J. | +3

7

Supportive care in cancer—a MASCC perspective

enthalten in: Supportive care in cancer | 2020

von Olver, I. | Keefe, D. | Herrstedt, J. | +3

8

Supportive care in cancer—a MASCC perspective

enthalten in: Supportive care in cancer | 2020

von Olver, I. | Keefe, D. | Herrstedt, J. | +3

9

Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2018

von Chow, R. | Warr, D. | Navari, R. | +6

10

Should palonosetron be a preferred 5-$ HT_{3} $ receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis

enthalten in: Supportive care in cancer | 2018

von Chow, R. | Warr, D. | Navari, R. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]